Chemical Name ALBUTEROL (al-BYOO-ter-ole)

PROAIR HFA is a medication prescribed to treat both bronchospasms in reversible obstructive airway disease (asthma) and to prevent exercise-induced bronchospasms. PROAIR HFA can be used in patients that are four years of age or older.

In patients with asthma and exercise-induced bronchospasms, the lungs constrict and tighten, making it difficult to take a full breath.

Albuterol works by attaching to beta-receptors on the surface of smooth muscle cells in the lungs. When albuterol attaches to beta-receptors, it causes the muscles that line lung tissue to relax, making it easier to breathe.

Directions

The normal dosage is Inhale one to two puffs every four to six hours as needed for coughing or wheezing. Your instructions may vary depending on your indication and the severity of your disease.

PROAIR HFA and other albuterol inhalers may be used for acute bronchospasms.

Ingredients

The active ingredient in PROAIR HFA is albuterol sulfate.

Each actuation contains 108 micrograms (mcg) of albuterol sulfate, equivalent to 90 mcg of albuterol base.

Each PROAIR HFA 90 mcg inhaler is 8.5 grams and contains 200 actuations.

Cautions

If you have to use more PROAIR HFA than prescribed by your doctor, it may be a sign that you need new or different treatment. Tell your doctor if you are using your inhaler more than prescribed.

Tell your doctor if you have a history of cardiovascular (heart) problems.

Tell your doctor if you have a history of low blood potassium, as the ingredient albuterol can cause changes in potassium.

Albuterol may cause changes in blood glucose. Use with caution if you have a history of diabetes.

Side Effects

The most common adverse reactions of PROAIR HFA may include:

• Dizziness
• Headache
• Pain
• Pharyngitis
• Rhinitis
• Tachycardia

Register To Save Up To 80% Off USA Prescriptions Now!
Receive a coupons. Discount specials will be emailed to
our valued customers as they become available.

References

1. ProAir HFA [package insert]. Waterford, Ireland: IVAX Pharmaceuticals; 2016.